Original language | English |
---|---|
Pages (from-to) | 1241-1243 |
Number of pages | 3 |
Journal | New England Journal of Medicine |
Volume | 385 |
Issue number | 13 |
DOIs | |
State | Published - Sep 23 2021 |
Breast cancer, HER2 mutations, and overcoming drug resistance
- Section of Molecular Oncology & Developmental Therapeutics
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Section of Medical Oncology
- DBBS - Molecular Cell Biology
- DBBS - Biochemistry, Biophysics, and Structural Biology
- DBBS - Cancer Biology
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Research output: Contribution to journal › Article › peer-review
19
Scopus
citations